|
|
Volumn 8, Issue 12, 1999, Pages 2189-2199
|
|
Pharmacology and clinical experience with bryostatin 1: A novel anticancer drug
|
|
Author keywords
Bryostatin 1; Drug resistance; Phorbol esters; PKC; Protein kinase C
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BRYOSTATIN 1;
CISPLATIN;
CLADRIBINE;
CYTARABINE;
FLUDARABINE;
PACLITAXEL;
PROTEIN KINASE C;
RETINOIC ACID;
TAMOXIFEN;
VINCRISTINE;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
BLOOD DISEASE;
CELL DIFFERENTIATION;
CLINICAL TRIAL;
CYTOTOXIC T LYMPHOCYTE;
DRUG MECHANISM;
DRUG SENSITIZATION;
DRUG STRUCTURE;
ENZYME ACTIVATION;
FLU LIKE SYNDROME;
GRANULOCYTE;
HEART ARRHYTHMIA;
HEMATOPOIESIS;
HUMAN;
HYPOTENSION;
IMMUNOMODULATION;
IN VITRO STUDY;
LEUKEMIA CELL;
LYMPHOCYTE;
LYMPHOMA CELL;
MELANOMA;
MONOCYTE;
MYALGIA;
NAUSEA;
NEUTROPENIA;
RADIOSENSITIVITY;
REVIEW;
THROMBOCYTE;
VOMITING;
|
|
EID: 0032721005
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.8.12.2189 Document Type: Review |
|
Times cited : (24)
|
|
References (90)
|
